Avantor (AVTR) Total Non-Current Liabilities (2018 - 2026)
Avantor (AVTR) recorded quarterly Total Non-Current Liabilities of $5.7 billion in Q1 2026, down 2.64% quarter-over-quarter from $5.9 billion in Q4 2025, and down 2.84% on a YoY basis from $5.9 billion in Q1 2025.
Avantor (AVTR) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Avantor's Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $5.7 billion for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 2.84% year-over-year to $5.7 billion; the TTM figure through Mar 2026 stood at $5.7 billion (down 2.84% YoY), while the FY2025 annual figure was $5.9 billion, up 0.9% from the prior year.
- Total Non-Current Liabilities was $5.7 billion for Q1 2026 at Avantor, down from $5.9 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $9.1 billion in Q1 2022 to a low of $5.7 billion in Q1 2026.
- Historically, Total Non-Current Liabilities has averaged $7.1 billion across 5 years, with a median of $7.1 billion in 2024.
- The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities jumped 38.98% in 2022, then fell 21.31% in 2024.
- A 5-year view of Total Non-Current Liabilities shows it stood at $8.3 billion in 2022, then dropped by 11.35% to $7.4 billion in 2023, then slipped by 21.31% to $5.8 billion in 2024, then increased by 0.9% to $5.9 billion in 2025, then dropped by 2.64% to $5.7 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $5.7 billion (Q1 2026), $5.9 billion (Q4 2025), and $5.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 24.24 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 17.13 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 941.16 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.03 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 8.65 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 3.98 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 2.10 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 12.54 Bn |
| 10 | Avantor | 6.47 Bn | 6.19 Bn | 500.70 Mn | 5.70 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.70 Bn |
| Dec 31, 2025 | 5.85 Bn |
| Sep 30, 2025 | 5.70 Bn |
| Jun 30, 2025 | 6.10 Bn |
| Mar 31, 2025 | 5.86 Bn |
| Dec 31, 2024 | 5.80 Bn |
| Sep 30, 2024 | 6.87 Bn |
| Jun 30, 2024 | 6.90 Bn |
| Mar 31, 2024 | 7.07 Bn |
| Dec 31, 2023 | 7.37 Bn |
| Sep 30, 2023 | 7.43 Bn |
| Jun 30, 2023 | 7.78 Bn |
| Mar 31, 2023 | 8.10 Bn |
| Dec 31, 2022 | 8.31 Bn |
| Sep 30, 2022 | 8.19 Bn |
| Jun 30, 2022 | 8.61 Bn |
| Mar 31, 2022 | 9.12 Bn |
| Dec 31, 2021 | 9.34 Bn |
| Sep 30, 2021 | 7.69 Bn |
| Jun 30, 2021 | 7.85 Bn |